ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK) HKSE

7.90

-0.37(-4.47%)

Updated at November 07 04:08PM

Currency In HKD

Valuation

Market Cap1.83B
Enterprise Value1.49B
P/E Ratio-9.73
PEG Ratio-1.36
Price/Sales Ratio23.17
Price/Book Ratio5.51
Enterprise/Revenue21.12
Enterprise/EBITDA-8.63

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-2.46
Operating Margin-2.53

Management Effectiveness

Return On Assets-0.39
Return On Equity-0.5

Income Statement

Revenue74.15M
Revenue/Share0.3
Gross Profit74.15M
EBITDA-295.63M
Net Income-315.86M
Diluted EPS-0.84

Balance Sheet

Total Cash703.7M
Total Cash/Share1
Total Debt153.72M
Total Debt/Equity0.29
Current Ratio3.33
Book Value Per Share1.31

Price History

52-Week Change-1.74
52-Week High16.8
52-Week Low4.31
Moving Average 50 Days11.53
Moving Average 200 Days9.26

Statistics

Average Volume3.72M
Shares Outstanding393.69M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A